30th January 2020
Trials are pleased to announce an updated policy for study protocol submissions. We continue to advise that study protocols are submitted to the journal well before recruitment completes, however as of today we will be considering exceptions to this rule. Trials will now consider study protocols submitted before the last piece of data is collected from the last participant if a clear statement outlining this, including an explanation of why it was not possible to submit earlier, is included within the manuscript text. Please confirm the status of your study at submission. For more information, please refer to our submission guidelines.
Study protocols policy
30th January 2020
9th December 2019
Trials is pleased to present a template for a structured study protocol, where all 51 SPIRIT headings and item identifers are included within the manuscript itself. Readers will benefit from the ability to search by item identifier, which are contained within curly brackets.
This is not mandatory and we will continue to consider protocols submitted in other formats against the SPIRIT checklist.
Read the Editorial from Shaun Treweek here: Protocols—more structure, less ‘Wuthering Heights’
Read the first published structured study protocol: Reducing Asthma Attacks in Children using Exhaled Nitric Oxide as a biomarker to inform treatment strategy: a randomised trial (RAACENO)
Introducing our Senior Editors
Peter Jüni joins Trials as co-Editor-in-Chief
23rd July 2019
We are delighted to announce Dr Peter Jüni as co-Editor-in-Chief for Trials. Peter is a clinical epidemiologist and general internist, and the Director of the Applied Health Research Centre (AHRC) at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He holds a Tier 1 Canada Research Chair in Clinical Epidemiology of Chronic Diseases and is a Professor at the Department of Medicine and the Institute of Health Policy, Management and Evaluation at the University of Toronto. Peter is known for his methodological work and for his clinical research on the management of cardiovascular and musculoskeletal disorders. He has had leading roles in major cardiovascular trials, served as a member of several task forces of the European Society of Cardiology, and contributed to the Cochrane Risk of Bias tools for randomized and non-randomized studies. Peter joins Jeremy Grimshaw, Tianjing Li and Shaun Treweek as co-Editor-in-Chief. Welcome Peter!
Thanks to all those who reviewed for Trials in 2018
26th June 2019
In 2018, 853 reviewers from 56 countries submitted peer-review reports for Trials. On behalf of the editors and staff of the journal, thank you all for your invaluable assistance.
View the full list here.
Erik Cobo steps down as Senior Editor
14th June 2019
Dr Erik Cobo has stood down from his role as Senior Editor for Trials. Dr. Cobo joined the journal as an Associate Editor and was promoted to the Senior Editor position in 2013, in which he has been a tremendous help to the running and development of the journal. On behalf of the Editors-in-Chief and BMC, we would like to express our thanks for all Erik's hard work with Trials and wish him all the best as he assumes new challenges at Barcelona-Tech, Catalonia, Spain
Annual Journal Metrics
135 days to first decision for reviewed manuscripts only
113 days to first decision for all manuscripts
196 days from submission to acceptance
31 days from acceptance to publication
1.975 - 2-year Impact Factor
2.258 - 5-year Impact Factor
0.873 - Source Normalized Impact per Paper (SNIP)
1.287 - SCImago Journal Rank (SJR)
6,653 Altmetric Mentions